ALC
Alcon Inc. - Registered Shares

552
Mkt Cap
$38.97B
Volume
1.09M
52W High
$99.20
52W Low
$71.55
PE Ratio
37.22
ALC Fundamentals
Price
$78.80
Prev Close
$78.76
Open
$78.77
50D MA
$76.42
Beta
0.78
Avg. Volume
2.46M
EPS (Annual)
$2.06
P/B
1.75
Rev/Employee
$387,163.56
Loading...
Loading...
News
all
press releases
Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation AGAINST STAAR Surgical Sale to Alcon
Broadwood Partners, L.P. and its affiliates (Broadwood or we) today announced that Glass, Lewis & Co., LLC (Glass Lewis), a leading independent proxy advisory firm, has reaffirmed its recommendation...
Business Wire·18h ago
News Placeholder
More News
News Placeholder
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today issued the following statement to...
Business Wire·2d ago
News Placeholder
Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
Broadwood Partners, L.P. and its affiliates (collectively, Broadwood, we, us or our) today reacted to the proxy statement supplement filed by STAAR Surgical Company (STAAR or the Company) (NASDAQ...
Business Wire·2d ago
News Placeholder
Yunqi Capital Comments on STAAR Surgicals Go-Shop Process and Alcons Revised Offer
Yunqi Capital Limited (together with its affiliates and the funds it advises, Yunqi Capital), an investment management firm and 5.1% shareholder of STAAR Surgical Company (STAAR or the Company...
Business Wire·3d ago
News Placeholder
STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’
STAAR rose after Alcon sweetened its offer, though Broadwood insists the company is “worth substantially more.”
Stocktwits·4d ago
News Placeholder
Broadwood Partners Responds to Alcons Increase to Proposed Acquisition Price of STAAR Surgical
Broadwood Partners, L.P. and its affiliates (collectively, Broadwood, we, us or our) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (STAAR or...
Business Wire·4d ago
News Placeholder
Alcon Announces Renewed STAAR Surgical Acquisition Deal At $30.75/Share In Cash
(RTTNews) - Alcon Inc. (ALC), Tuesday announced an amended merger agreement for the acquisition of STAAR Surgical Company (STAA), intending to purchase outstanding stock of the latter for $30.75 per...
Nasdaq News: Markets·4d ago
News Placeholder
Alcon Announces Amended Merger Agreement with STAAR Surgical
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger agreement for the acquisition of STAAR...
Business Wire·4d ago
News Placeholder
Broadwood Partners Reiterates Opposition to STAAR Surgicals Sale to Alcon Following Conclusion of Performative Go-Shop Process
Broadwood Partners, L.P. and its affiliates (collectively, Broadwood, we, us, or our) today issued the following open letter to the shareholders of STAAR Surgical Company (STAAR or the Company...
Business Wire·5d ago
News Placeholder
Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote AGAINST Sale to Alcon
Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today announced that leading proxy advisory firm Egan-Jones Ratings Company (Egan-Jones) has reaffirmed its recommendation that...
Business Wire·5d ago

Latest ALC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.